Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04310644

Autonomic Small Fiber Neuropathy and Ehlers Danlos Syndromes - Prospective Study and Registry

Autonomic Neuropathy and Its Pathophysiology in Autoimmune Autonomic Neuropathies, Postural Orthostatic Tachycardia Syndrome and Ehlers Danlos Syndromes: Peripheral Autonomic Small Fiber Neuropathy or Central Autonomic Failure? Validation of the Malmö POTS Score and a Better Diagnosis of POTS in Patientes With Autnomic Failure (VaGeMAPS-3-step-Diag)

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
RWTH Aachen University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

We examine patients with different autonomic neuropathies and Ehlers Danlos syndromes compared to healthy controls at three different points over time (baseline, after 3 months and after 1.5 years) to gain knowledge about the course of this disease and understand its pathophysiology, with a focus on Small Fiber neuropathy. Moreover we will validate the german version of the Malmö POTS Score and establish an easy diagnostic scheme for patients in outpatient care.

Detailed description

Inclusion of patients with autoimmune autonomic neuropathies/ pure autonomic failure, postural orthostatic tachycardia syndrome, small fiber neuropathies, Ehlers-Danlos syndromes, Mast cell activation syndrom, Chronic fatigue syndrome and PostCOVID syndrome in our Registry study with follow up visits. Comparison to healthy controls concerning selected examinations. Planned examinations are laboratory tests, questionnaires on mental and physical health status and circulatory disorders, attention tests, tilt table testing, standing test, sweat function, investigation of small fiber function via quantitative sensory testing as well as the density of nerve fibers in the skin. Measurements are performed at baseline mostly in clinical routine and follow up visits are offered.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention planned, but all patients get our standart treatmentPatients are selected from clinical Routine and get our standart Treatment based on their disease

Timeline

Start date
2019-09-15
Primary completion
2028-09-15
Completion
2029-09-15
First posted
2020-03-17
Last updated
2025-02-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04310644. Inclusion in this directory is not an endorsement.